ASCO and Tempus Collaborate to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization TAPUR Study

ASCO and Tempus Collaborate to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization (TAPUR) Study

09:22 EST 11 Jan 2019 | Speciality Pharma Journal

ALEXANDRIA, Va. and CHICAGO, Jan. 10, 2019 (GLOBE NEWSWIRE) — The American Society of Clinical Oncology, Inc. (ASCO) and Tempus announced today an agreement to support research sites participating in ASCO’s Targeted Agent and Profiling Utilization (TAPUR™) Study. The TAPUR Study is a prospective, non-randomized clinical trial that aims to describe the performance (both safety …

More From BioPortfolio on "ASCO and Tempus Collaborate to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization (TAPUR) Study"